A new glycociamidine ring precursor: Syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (±)-endo-2-debromohymenialdisine

Organic Letters

Volumn 7, Issue 25, 2005, Pages 5641-5644

  Papeo, Gianluca ^a   Posteri, Helena ^a   Borghi, Daniela ^a   Varasi, Mario ^a  

^a Nerviano Medical Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AZEPINE DERIVATIVE; DEBROMOHYMENIALDISINE; HYMENIALDISINE; PYRROLE DERIVATIVE;

ANIMAL; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; SPONGE (PORIFERA); STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; ANIMALS; AZEPINES; CYCLIZATION; MARINE BIOLOGY; MOLECULAR STRUCTURE; PORIFERA; PYRROLES; STEREOISOMERISM;

EID: 29444445314     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol052266m     Document Type: Article

References (42)

1. (a) Cimino, G.; De Rosa, S.; De Stefano, S.; Mazzarella, L.; Puliti, L.; Sodano, G. Tetrahedron Lett. 1982, 23, 767.
2. (b) Kitagawa, I.; Kobayashi, M.; Kitanaka, K.; Kido, M.; Kyogoku, Y. Chem. Pharm. Bull. 1983, 31, 2321.
3. Groszek, G.; Kantoci, D.; Pettit, G R. Liebigs Ann. 1995, 4, 715.
4. (a) Supriyono, A.; Schwarz, B.; Wray, V.; Witte, L.; Muller, W. E.; Van Soest, R.; Sumaryono, W.; Proksch, P. J. Biosci. 1995, 50, 669.
5. (b) Eder, C.; Proksch, P.; Wray, V.; Steube, K.; Bringmann, G.; Van Soest, R. W. M.; Ferdinandus, E.; Pattisina, L.; Wiryowidagdo, S.; Moka, W. J. Nat. Prod. 1999, 62, 184.
6. (a) For an exhaustive review on pyrrole-imidazole alkaloids, see: Hoffmann, H.; Lindel, T. Synthesis 2003, 2, 1753.
7. (b) Zhoung, J. Nat. Prod. Rep. 2005, 2, 196.
8. Williams, D. H.; Faulkner, J. Nat. Prod. Lett. 1996, 9, 57.
9. See, for example: (a) Chanas, B.; Pawlik, J. R.; Lindel, T.; Fenical, W. J. Exp. Mar. Biol. Ecol. 1996, 208, 185.
10. (b) Wilson, D. M.; Puyana, M.; Fenical, W.; Pawlik, J. R. J. Chem. Ecol. 1999, 25, 2811.
11. (c) Lindel, T.; Hoffmann, H.; Hochgurtel, M.; Pawlik, J. J. Chem. Ecol. 2000, 26, 1744.
12. (a) Andrade, P.; Willoughby, R.; Pomponi, S. A.; Kerr, R. G. Tetrahedron Lett. 1999, 40, 4775.
13. (b) Al Mourabit, A.; Potier, P. Eur. J. Org. Chem. 2001, 237.
14. (c) Linington, R. G.; Williams, D. E.; Tahir, A.; Van Soest, R.; Andersen, R. J. Org. Lett. 2003, 5, 2735.
15. (d) Travert, N.; Al- Mourabit. A. J. Am. Chem. Soc. 2004, 126, 10252.
16. (a) Tasdemir, D.; Mallon, R.; Greenstein, M.; Feldberg, L. R.; Kim, S. C.; Collins, K.; Wojciechowicz, D.; Mangalindan, G. C.; Concepciòn, G. P.; Harper, M. K.; Ireland, C. M. J. Med. Chem. 2002, 45, 529.
17. (b) Wan, Y.; Hur, W.; Cho, C Y.; Liu, Y.; Adrian, F J.; Lozach, O.; Bach, S.; Mayer, T.; Fabbro, D.; Meijer, L.; Gray, N. S. Chem. Biol. 2004, 11, 247.
18. (a) Meijer, L.; Thunnissen, A. M.; White, A. W.; Gamier, M.; Nikolic, M.; Tsai, L. H.; Walter, J.; Cleverley, K. E.; Salinas, P. C.; Wu, Y. Z.; Biernat, J.; Mandelkow, E. M.; Kim, S. H.; Pettit, G. R. Chem. biol. 2000, 7, 51.
19. (b) Meijer, L. Eur. Patent Appl. EP 1106180, 2001, 38 pp.
20. Curman, D.; Cinel, B.; Williams, D. E.; Rundle, N.; Block, W. D.; Goodarzi, A. A.; Hutchins, J. R.; Clarke, P. R.; Zhou, B.-B.; Lees-Miller, S. P.; Andersen, R. J.; Roberge, M. J. Biol. Chem. 2001, 276, 17914.
21. (a) Albrecht, T.; Meijer, L.; Schaffer, P.; Schang, L. PCT Int. Appl. 2002, 139 pp.
22. (b) Roshak, A.; Jackson, J. R.; Chabot-Fletcher, M.; Marshall, L A. J. Pharm. Exp. Ther. 1997, 283, 955.
23. Kawabe, T. Mol. Can. Ther. 2004, 3, 513.
24. (a) Inoue, H.; Takamori, M.; Nagata, N.; Nishikawa, T.; Oda, H.; Yamamoto, S.; Koshihara, Y. Inflamm. Res. 2001, 50, 65.
25. (b) Chipman, S.; Faulkner, D. J. U.S. Patent 5591740, 1997, 11 pp.
26. (c) DiMartino, M.; Wolff, C.; Patil, A.; Nambi, P. Inflamm. Res. 1995, 44, 123.
27. Helberg, M. R.; Clark, A. F.; Abbot, F.; Pang, I.; Helberg, P. E.; McNatt, L.; Wang, H. PCT Int. Appl. WO 2003027275, 2003.
28. Barrios Sosa, A. C.; Yakushijin, K.; Horne, D. A. J. Org. Chem. 2000, 05, 610.
29. Portevin, B.; Golsteyn, R. M.; Pierré, A.; De Nanteuil, G. Tetrahedron Lett. 2003, 44, 9263.
30. (a) Annoura, H.; Tatsuoka, T. Tetrahedron Lett. 1995, 36, 413.
31. (b) Xu, Y.-Z.; Yakushijin, K.; Horne, D. A. J. Org. Chem. 1997, 62, 456.
32. (a) See, for example: Matsuki, S.; Mizuno, A.; Annoura, H.; Tatsuoka, T. J. Heterocycl. Chem. 1997, 34, 87.
33. (b) Kasum, B.; Prager, R. H.; Tsopelas, C. Aust. J. Chem. 1990, 43, 355.
34. (a) Feldman, K. S.; Saunders, J. C.; Laci Wrobleski, M. J. Org. Chem. 2002, 67, 7096.
35. (b) Domostoj, M. M.; Irving, E.; Scheinmann, F.; Hale, K. J. Org. Lett. 2004, 6, 2615.
36. (a) Sharma, V.; Lansdell, T. A.; Jin, G.; Tepe, J. J. J. Med. Chem. 2004, 47, 3700-3703.
37. (b) Sharma, V.; Tepe, J. J. Bioorg. Med. Chem. Lett. 2004, 14, 4319.
38. Prager, R. H.; Tsopelas, C. Aust. J. Chem. 1992, 45, 1771.
39. For a review on azlactones chemistry, see: Mukerjee, A. K. Heterocycles 1987, 26, 1077.
40. For a review, see: Hwu, J. R.; Gilbert, B. A. Tetrahedron 1989, 45, 1233.
41. Roué, N.; Bergman, J. Tetrahedron 1999, 55, 14729.
42. Johnson, T. B.; Hill, A. J.; Bailey, B. H. J. Am. Chem. Soc. 1915, 37, 2406.